Weighing shadows: can meta-analysis help define the risk-benefit ratio of RAI treatment for low-risk thyroid cancer patients?

Thyroid. 2009 May;19(5):435-6. doi: 10.1089/thy.2009.0091.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Iodine Radioisotopes / adverse effects*
  • Leukemia, Radiation-Induced / etiology
  • Meta-Analysis as Topic*
  • Neoplasms, Radiation-Induced / etiology*
  • Neoplasms, Second Primary / etiology*
  • Patient Selection
  • Risk Assessment
  • Risk Factors
  • Thyroid Neoplasms / radiotherapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Iodine Radioisotopes